IL133242A0 - 5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application - Google Patents
5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic applicationInfo
- Publication number
- IL133242A0 IL133242A0 IL13324298A IL13324298A IL133242A0 IL 133242 A0 IL133242 A0 IL 133242A0 IL 13324298 A IL13324298 A IL 13324298A IL 13324298 A IL13324298 A IL 13324298A IL 133242 A0 IL133242 A0 IL 133242A0
- Authority
- IL
- Israel
- Prior art keywords
- naphthalene
- preparation
- therapeutic application
- dioxane derivatives
- dioxane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9706944A FR2764287B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
FR9706946A FR2764289B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
FR9706947A FR2764291B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
FR9706945A FR2764288B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
PCT/FR1998/001113 WO1998055474A1 (fr) | 1997-06-05 | 1998-06-03 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
IL133242A0 true IL133242A0 (en) | 2001-03-19 |
Family
ID=27447000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13324298A IL133242A0 (en) | 1997-06-05 | 1998-06-03 | 5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0986552A1 (xx) |
JP (1) | JP2002502412A (xx) |
KR (1) | KR20010013435A (xx) |
CN (1) | CN1265658A (xx) |
AR (1) | AR012908A1 (xx) |
AU (1) | AU8025198A (xx) |
BG (1) | BG103937A (xx) |
BR (1) | BR9810742A (xx) |
CA (1) | CA2290695A1 (xx) |
CO (1) | CO4940480A1 (xx) |
EE (1) | EE9900560A (xx) |
HU (1) | HUP0002166A3 (xx) |
IL (1) | IL133242A0 (xx) |
NO (1) | NO995966L (xx) |
PL (1) | PL337234A1 (xx) |
SK (1) | SK166199A3 (xx) |
TR (1) | TR199903022T2 (xx) |
WO (1) | WO1998055474A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1250213C (zh) * | 2000-07-21 | 2006-04-12 | 奥索-麦克尼尔药品公司 | 用于预防或治疗神经性疼痛和丛集性头痛及有或没有先兆的偏头痛的氨基甲酸酯化合物 |
FR2843964B1 (fr) * | 2002-08-29 | 2004-10-01 | Sanofi Synthelabo | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0461958T3 (da) * | 1990-06-15 | 1995-02-20 | Synthelabo | 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien |
FR2714055B1 (fr) * | 1993-12-22 | 1996-01-19 | Synthelabo | Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique. |
FR2742152B1 (fr) * | 1995-12-06 | 1998-01-16 | Synthelabo | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
-
1998
- 1998-06-03 EE EEP199900560A patent/EE9900560A/xx unknown
- 1998-06-03 BR BR9810742-9A patent/BR9810742A/pt not_active IP Right Cessation
- 1998-06-03 EP EP98928419A patent/EP0986552A1/fr not_active Withdrawn
- 1998-06-03 PL PL98337234A patent/PL337234A1/xx unknown
- 1998-06-03 CA CA002290695A patent/CA2290695A1/en not_active Abandoned
- 1998-06-03 JP JP50172399A patent/JP2002502412A/ja active Pending
- 1998-06-03 TR TR1999/03022T patent/TR199903022T2/xx unknown
- 1998-06-03 AR ARP980102585A patent/AR012908A1/es unknown
- 1998-06-03 SK SK1661-99A patent/SK166199A3/sk unknown
- 1998-06-03 IL IL13324298A patent/IL133242A0/xx unknown
- 1998-06-03 HU HU0002166A patent/HUP0002166A3/hu unknown
- 1998-06-03 KR KR1019997011436A patent/KR20010013435A/ko not_active Application Discontinuation
- 1998-06-03 CN CN98807817A patent/CN1265658A/zh active Pending
- 1998-06-03 AU AU80251/98A patent/AU8025198A/en not_active Abandoned
- 1998-06-03 WO PCT/FR1998/001113 patent/WO1998055474A1/fr not_active Application Discontinuation
- 1998-06-04 CO CO98031750A patent/CO4940480A1/es unknown
-
1999
- 1999-11-30 BG BG103937A patent/BG103937A/xx unknown
- 1999-12-03 NO NO995966A patent/NO995966L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0002166A2 (hu) | 2001-06-28 |
BR9810742A (pt) | 2000-09-12 |
AR012908A1 (es) | 2000-11-22 |
NO995966L (no) | 2000-02-04 |
EP0986552A1 (fr) | 2000-03-22 |
BG103937A (en) | 2000-07-31 |
CA2290695A1 (en) | 1998-12-10 |
JP2002502412A (ja) | 2002-01-22 |
HUP0002166A3 (en) | 2002-12-28 |
CN1265658A (zh) | 2000-09-06 |
PL337234A1 (en) | 2000-08-14 |
CO4940480A1 (es) | 2000-07-24 |
KR20010013435A (ko) | 2001-02-26 |
EE9900560A (et) | 2000-06-15 |
NO995966D0 (no) | 1999-12-03 |
WO1998055474A1 (fr) | 1998-12-10 |
TR199903022T2 (xx) | 2000-04-21 |
SK166199A3 (en) | 2000-06-12 |
AU8025198A (en) | 1998-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1015765A1 (en) | Dithiolan derivatives, their preparation and their therapeutic effect | |
LT2000004A (en) | Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments | |
AU6721598A (en) | Dioxino derivatives and their use as therapeutic agents | |
PL343512A1 (en) | Thienylazolylalcoxyethanamines, their preparation and their application as medicaments | |
HK1040398A1 (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
ZA989556B (en) | Benzoxazine derivatives their preparation and their therapeutic application | |
HUP9904206A3 (en) | 1,4-diazabicyclo[2.2.2.]oct-2-ylmethyl derivatives,their preparation and therapeutic application | |
ZA9810558B (en) | Imidazole derivatives their preparation and their therapeutic application | |
IL135520A0 (en) | 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application | |
ZA9610251B (en) | 5-Naphthalen-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application | |
IL133536A0 (en) | 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy | |
HUP0203468A3 (en) | Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof | |
IL133242A0 (en) | 5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application | |
AU3153199A (en) | Azacycloalkane derivatives, preparation and therapeutic application | |
ZA984854B (en) | 5-Naphthalene-1-YL-1,3-Dioxane derivatives their preparation and their therapeutic application | |
AU1566599A (en) | 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, preparation and therapeutic application | |
ZA975771B (en) | 1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, their preparation and their therapeutic application. | |
HUP0002403A3 (en) | Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them | |
AU5005099A (en) | Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof | |
AU5522499A (en) | 2-aminoethyl-quinoline derivatives, preparation and therapeutic use | |
AU6218598A (en) | Alpha-azacyclomethyl benzothiophene and alpha-azacyclomethyl benzofurane derivatives, preparation and therapeutic application | |
GB9414350D0 (en) | Heterocyclic compounds, their preparation and their therapeutic use | |
GB9423948D0 (en) | Heterocyclic compounds, their preparation and their therapeutic use | |
GB9415175D0 (en) | Heterocyclic compounds, their preparation and their therapeutic use | |
ZA986340B (en) | Medicaments comprising polyhydroxyalkylpyrazine derivatives novel polyhydrosyalkylpyrazine derivatives and their preparation |